Skip to content
2000
Volume 33, Issue 8
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background

The precise function of DDX59 Antisense RNA 1 (DDX59-AS1) in lung adenocarcinoma (LUAD) has yet to be fully elucidated.

Objective

This study uses bioinformatics analysis and experimental validation to investigate the association between DDX59-AS1 and LUAD.

Methods

This study uses statistical analysis and database interrogation to investigate the potential association between DDX59-AS1 expression and various clinical characteristics, prognostic factors, regulatory networks, and immune infiltration in LUAD. The quantification of DDX59-AS1 expression in LUAD cell lines is conducted through the use of quantitative real-time polymerase chain reaction (qRT-PCR).

Results

DDX59-AS1 showed significantly elevated levels of expression in patients with LUAD. High levels of DDX59-AS1 expression were found to be significantly associated with poorer overall survival (OS) in patients with LUAD ( = 0.024). Furthermore, an independent correlation was observed between high DDX59-AS1 expression ( = 0.037) and OS in LUAD patients. DDX59-AS1 was found to be involved in various pathways, including glutathione metabolism, proteasome function, and the cytosolic DNA sensing pathway, among others. A significant correlation was observed between the expression levels of DDX59-AS1 and immune cell infiltration in the context of LUAD. Notably, elevated expression of DDX59-AS1 was observed in LUAD cell lines compared to the non-cancerous Beas-2B cell line.

Conclusion

A significant correlation was observed between elevated DDX59-AS1 expression in patients with LUAD and adverse prognosis, alongside increased immune infiltration. These results indicate that DDX59-AS1 may function as a prognostic marker for LUAD and a potential predictor of immunotherapy response.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673359149250212073143
2025-02-18
2026-03-07

  • From This Site

    /content/journals/cmc/10.2174/0109298673359149250212073143
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ChenW. ZhengR. BaadeP.D. ZhangS. ZengH. BrayF. JemalA. YuX.Q. HeJ. Cancer statistics in China, 2015.CA Cancer J. Clin.201666211513210.3322/caac.2133826808342
     [Google Scholar]
  2. ZhengY. ZhangZ. LiX. WuL. LiuX. LiuL. ChenJ. WeiD. LINC01572 is a novel prognostic biomarker and therapeutic target in lung adenocarcinoma.Front. Biosci.-Landma.2023281025710.31083/j.fbl281025737919058
     [Google Scholar]
  3. WangL. ShangM. DaiQ. HeP. Prediction of lncRNA-disease association based on a Laplace normalized random walk with restart algorithm on heterogeneous networks.BMC Bioinf.2022231510.1186/s12859‑021‑04538‑134983367
     [Google Scholar]
  4. XiaoJ. ChenX. LuX. XieM. HeB. HeS. YouS. ChenQ. Progesterone/Org inhibits lung adenocarcinoma cell growth via membrane progesterone receptor alpha.Thorac. Cancer20201182209222310.1111/1759‑7714.1352832529777
     [Google Scholar]
  5. BaraibarI. RomanM. Rodríguez-RemírezM. LópezI. VilaltaA. GuruceagaE. EcayM. CollantesM. LozanoT. AlignaniD. PuyaltoA. OliverA. Ortiz-EspinosaS. MorenoH. TorregrosaM. RolfoC. CaglevicC. García-RosD. Villalba-EsparzaM. De AndreaC. VicentS. PíoR. LasarteJ.J. CalvoA. AjonaD. Gil-BazoI. Id1 and PD-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-L1 expression and tumor infiltrating CD8+ T cells.Cancers (Basel)20201211316910.3390/cancers1211316933126649
     [Google Scholar]
  6. ChenS. HuangC. JinE. Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression.J. Cardiothorac. Surg.20241918810.1186/s13019‑024‑02507‑238347625
     [Google Scholar]
  7. ZhangR. MaL. LiW. ZhouS. XuS. Diagnostic value of multiple tumor-associated autoantibodies in lung cancer.OncoTargets Ther.20191245746910.2147/OTT.S18773430666125
     [Google Scholar]
  8. KangJ. AbudurufuM. ZhangS. JiangW. LuoH. lncRNA VIM-AS1 acts as a prognostic biomarker and promotes apoptosis in lung adenocarcinoma.J. Cancer20231481417142610.7150/jca.8363937283796
     [Google Scholar]
  9. AdnaneS. MarinoA. LeucciE. LncRNAs in human cancers: Signal from noise.Trends Cell Biol.202232756557310.1016/j.tcb.2022.01.00635168846
     [Google Scholar]
  10. KarakasD. OzpolatB. The role of LncRNAs in translation.Noncoding RNA2021711610.3390/ncrna701001633672592
     [Google Scholar]
  11. SunY. ZhouQ. SunJ. BiW. LiR. WuX. LiN. SongL. YangF. YuY. DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC.Front. Genet.20221389272710.3389/fgene.2022.89272736081993
     [Google Scholar]
  12. YiW. ShenH. SunD. XuY. FengY. LiD. WangC. Low expression of long noncoding RNA SLC26A4 antisense RNA 1 is an independent prognostic biomarker and correlate of immune infiltrates in breast cancer.Med. Sci. Monit.202127e93452234880202
     [Google Scholar]
  13. LiangW. LuY. PanX. ZengY. ZhengW. LiY. NieY. LiD. WangD. Decreased expression of a novel lncRNA FAM181A-AS1 is associated with poor prognosis and immune infiltration in lung adenocarcinoma.Pharm. Genomics Pers. Med.20221598599810.2147/PGPM.S38490136482943
     [Google Scholar]
  14. HanQ. CuiZ. WangQ. PangF. LiD. WangD. Upregulation of OTX2-AS1 is associated with immune infiltration and predicts prognosis of gastric cancer.Technol. Cancer Res. Treat.2023221533033823115409110.1177/1533033823115409136740995
     [Google Scholar]
  15. LiZ. JinY. QueT. ZhangX.A. YiG. ZhengH. Identification of necroptosis-related molecular subtypes and construction of necroptosis-related gene signature for glioblastoma multiforme.Curr. Med. Chem.202331335417543137539935
     [Google Scholar]
  16. CaiH. ChenS. WuZ. WangF. TangS. LiD. WangD. GuoW. Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma.Aging (Albany NY)20231522130411305810.18632/aging.20521837980166
     [Google Scholar]
  17. WangS. ZhouL. JiN. SunC. SunL. SunJ. DuY. ZhangN. LiY. LiuW. LuW. Targeting ACYP1- mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression.Drug Resist. Updat.20236910097610.1016/j.drup.2023.10097637210811
     [Google Scholar]
  18. ChenB. DingX. WanA. QiX. LinX. WangH. MuW. WangG. ZhengJ. Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer.Sci. Rep.20231311624410.1038/s41598‑023‑42171‑537758722
     [Google Scholar]
  19. ZhangZ. LiuS. GaoT. YangY. LiQ. ZhaoL. A novel immune-related prognostic signature based on Chemoradiotherapy sensitivity predicts long-term survival in patients with esophageal squamous cell carcinoma.PeerJ202311e1583910.7717/peerj.1583937609436
     [Google Scholar]
  20. FuZ. LaiY. WangQ. LinF. FangJ. LRG1 predicts the prognosis and is associated with immune infiltration in thyroid cancer: A bioinformatics study.Endocr. Connect.2023131e23041810.1530/EC‑23‑041837991216
     [Google Scholar]
  21. GkirgkirisK. PapoutsiE. AthanasiouN. GκoufasS. SiemposI.I. Drug-overdose associated acute hypoxemic respiratory failure: A secondary analysis.Pneumon.20243711810.18332/pne/176933
     [Google Scholar]
  22. LuR. LiY. XieyidaiA. YuT. FengY. Exploring the role of DKK1 in the occurrence of lung adenocarcinoma based on the analysis of bioinformatics.Chin. J. Lung Cancer202326857959037752538
     [Google Scholar]
  23. ChenJ. TangH. LiT. JiangK. ZhongH. WuY. HeJ. LiD. LiM. CaiX. Comprehensive analysis of the expression, prognosis, and biological significance of OVOLs in breast cancer.Int. J. Gen. Med.2021143951396010.2147/IJGM.S32640234345183
     [Google Scholar]
  24. ChenY.C. LiD.B. WangD.L. PengH. Comprehensive analysis of distal-less homeobox family gene expression in colon cancer.World J. Gastrointest. Oncol.20231561019103510.4251/wjgo.v15.i6.101937389108
     [Google Scholar]
  25. YangD. LiuM. JiangJ. LuoY. WangY. ChenH. LiD. WangD. YangZ. ChenH. Comprehensive analysis of DMRT3 as a potential biomarker associated with the immune infiltration in a pan-cancer analysis and validation in lung adenocarcinoma.Cancers (Basel)20221424622010.3390/cancers1424622036551704
     [Google Scholar]
  26. LiuJ. LichtenbergT. HoadleyK.A. PoissonL.M. LazarA.J. CherniackA.D. KovatichA.J. BenzC.C. LevineD.A. LeeA.V. OmbergL. WolfD.M. ShriverC.D. ThorssonV. HuH. Caesar-JohnsonS.J. DemchokJ.A. FelauI. KasapiM. FergusonM.L. HutterC.M. SofiaH.J. TarnuzzerR. WangZ. YangL. ZenklusenJ.C. ZhangJ.J. ChudamaniS. LiuJ. LollaL. NareshR. PihlT. SunQ. WanY. WuY. ChoJ. DeFreitasT. FrazerS. GehlenborgN. GetzG. HeimanD.I. KimJ. LawrenceM.S. LinP. MeierS. NobleM.S. SaksenaG. VoetD. ZhangH. BernardB. ChambweN. DhankaniV. KnijnenburgT. KramerR. LeinonenK. LiuY. MillerM. ReynoldsS. ShmulevichI. ThorssonV. ZhangW. AkbaniR. BroomB.M. HegdeA.M. JuZ. KanchiR.S. KorkutA. LiJ. LiangH. LingS. LiuW. LuY. MillsG.B. NgK-S. RaoA. RyanM. WangJ. WeinsteinJ.N. ZhangJ. AbeshouseA. ArmeniaJ. ChakravartyD. ChatilaW.K. de BruijnI. GaoJ. GrossB.E. HeinsZ.J. KundraR. LaK. LadanyiM. LunaA. NissanM.G. OchoaA. PhillipsS.M. ReznikE. Sanchez-VegaF. SanderC. SchultzN. SheridanR. SumerS.O. SunY. TaylorB.S. WangJ. ZhangH. AnurP. PetoM. SpellmanP. BenzC. StuartJ.M. WongC.K. YauC. HayesD.N. ParkerJ.S. WilkersonM.D. AllyA. BalasundaramM. BowlbyR. BrooksD. CarlsenR. ChuahE. DhallaN. HoltR. JonesS.J.M. KasaianK. LeeD. MaY. MarraM.A. MayoM. MooreR.A. MungallA.J. MungallK. RobertsonA.G. SadeghiS. ScheinJ.E. SipahimalaniP. TamA. ThiessenN. TseK. WongT. BergerA.C. BeroukhimR. CherniackA.D. CibulskisC. GabrielS.B. GaoG.F. HaG. MeyersonM. SchumacherS.E. ShihJ. KucherlapatiM.H. KucherlapatiR.S. BaylinS. CopeL. DanilovaL. BootwallaM.S. LaiP.H. MaglinteD.T. Van Den BergD.J. WeisenbergerD.J. AumanJ.T. BaluS. BodenheimerT. FanC. HoadleyK.A. HoyleA.P. JefferysS.R. JonesC.D. MengS. MieczkowskiP.A. MoseL.E. PerouA.H. PerouC.M. RoachJ. ShiY. SimonsJ.V. SkellyT. SolowayM.G. TanD. VeluvoluU. FanH. HinoueT. LairdP.W. ShenH. ZhouW. BellairM. ChangK. CovingtonK. CreightonC.J. DinhH. DoddapaneniH.V. DonehowerL.A. DrummondJ. GibbsR.A. GlennR. HaleW. HanY. HuJ. KorchinaV. LeeS. LewisL. LiW. LiuX. MorganM. MortonD. MuznyD. SantibanezJ. ShethM. ShinbroE. WangL. WangM. WheelerD.A. XiL. ZhaoF. HessJ. AppelbaumE.L. BaileyM. CordesM.G. DingL. FronickC.C. FultonL.A. FultonR.S. KandothC. MardisE.R. McLellanM.D. MillerC.A. SchmidtH.K. WilsonR.K. CrainD. CurleyE. GardnerJ. LauK. MalleryD. MorrisS. PaulauskisJ. PennyR. SheltonC. SheltonT. ShermanM. ThompsonE. YenaP. BowenJ. Gastier-FosterJ.M. GerkenM. LeraasK.M. LichtenbergT.M. RamirezN.C. WiseL. ZmudaE. CorcoranN. CostelloT. HovensC. CarvalhoA.L. de CarvalhoA.C. FregnaniJ.H. Longatto-FilhoA. ReisR.M. Scapulatempo-NetoC. SilveiraH.C.S. VidalD.O. BurnetteA. EschbacherJ. HermesB. NossA. SinghR. AndersonM.L. CastroP.D. IttmannM. HuntsmanD. KohlB. LeX. ThorpR. AndryC. DuffyE.R. LyadovV. PaklinaO. SetdikovaG. ShabuninA. TavobilovM. McPhersonC. WarnickR. BerkowitzR. CramerD. FeltmateC. HorowitzN. KibelA. MutoM. RautC.P. MalykhA. Barnholtz-SloanJ.S. BarrettW. DevineK. FulopJ. OstromQ.T. ShimmelK. WolinskyY. SloanA.E. De RoseA. GiulianteF. GoodmanM. KarlanB.Y. HagedornC.H. EckmanJ. HarrJ. MyersJ. TuckerK. ZachL.A. DeyarminB. HuH. KvecherL. LarsonC. MuralR.J. SomiariS. VichaA. ZelinkaT. BennettJ. IacoccaM. RabenoB. SwansonP. LatourM. LacombeL. TêtuB. BergeronA. McGrawM. StaugaitisS.M. ChabotJ. HibshooshH. SepulvedaA. SuT. WangT. PotapovaO. VoroninaO. DesjardinsL. MarianiO. Roman-RomanS. SastreX. SternM-H. ChengF. SignorettiS. BerchuckA. BignerD. LippE. MarksJ. McCallS. McLendonR. SecordA. SharpA. BeheraM. BratD.J. ChenA. DelmanK. ForceS. KhuriF. MaglioccaK. MaithelS. OlsonJ.J. OwonikokoT. PickensA. RamalingamS. ShinD.M. SicaG. Van MeirE.G. ZhangH. EijckenboomW. GillisA. KorpershoekE. LooijengaL. OosterhuisW. StoopH. van KesselK.E. ZwarthoffE.C. CalatozzoloC. CuppiniL. CuzzubboS. DiMecoF. FinocchiaroG. MatteiL. PerinA. PolloB. ChenC. HouckJ. LohavanichbutrP. HartmannA. StoehrC. StoehrR. TaubertH. WachS. WullichB. KyclerW. MurawaD. WiznerowiczM. ChungK. EdenfieldW.J. MartinJ. BaudinE. BubleyG. BuenoR. De RienzoA. RichardsW.G. KalkanisS. MikkelsenT. NoushmehrH. ScarpaceL. GirardN. AymerichM. CampoE. GinéE. GuillermoA.L. Van BangN. HanhP.T. PhuB.D. TangY. ColmanH. EvasonK. DottinoP.R. MartignettiJ.A. GabraH. JuhlH. AkeredoluT. StepaS. HoonD. AhnK. KangK.J. BeuschleinF. BreggiaA. BirrerM. BellD. BoradM. BryceA.H. CastleE. ChandanV. ChevilleJ. CoplandJ.A. FarnellM. FlotteT. GiamaN. HoT. KendrickM. KocherJ-P. KoppK. MoserC. NagorneyD. O’BrienD. O’NeillB.P. PatelT. PetersenG. QueF. RiveraM. RobertsL. SmallridgeR. SmyrkT. StantonM. ThompsonR.H. TorbensonM. YangJ.D. ZhangL. BrimoF. AjaniJ.A. Angulo GonzalezA.M. BehrensC. BondarukJ. BroaddusR. CzerniakB. EsmaeliB. FujimotoJ. GershenwaldJ. GuoC. LazarA.J. LogothetisC. Meric-BernstamF. MoranC. RamondettaL. RiceD. SoodA. TamboliP. ThompsonT. TroncosoP. TsaoA. WistubaI. CarterC. HayduL. HerseyP. JakrotV. KakavandH. KeffordR. LeeK. LongG. MannG. QuinnM. SawR. ScolyerR. ShannonK. SpillaneA. StretchJ. SynottM. ThompsonJ. WilmottJ. Al-AhmadieH. ChanT.A. GhosseinR. GopalanA. LevineD.A. ReuterV. SingerS. SinghB. TienN.V. BroudyT. MirsaidiC. NairP. DrwiegaP. MillerJ. SmithJ. ZarenH. ParkJ-W. HungN.P. KebebewE. LinehanW.M. MetwalliA.R. PacakK. PintoP.A. SchiffmanM. SchmidtL.S. VockeC.D. WentzensenN. WorrellR. YangH. MoncrieffM. GoparajuC. MelamedJ. PassH. BotnariucN. CaramanI. CernatM. ChemencedjiI. ClipcaA. DorucS. GorincioiG. MuraS. PirtacM. StanculI. TcaciucD. AlbertM. AlexopoulouI. ArnaoutA. BartlettJ. EngelJ. GilbertS. ParfittJ. SekhonH. ThomasG. RasslD.M. RintoulR.C. BifulcoC. TamakawaR. UrbaW. HaywardN. TimmersH. AntenucciA. FaccioloF. GraziG. MarinoM. MerolaR. de KrijgerR. Gimenez-RoqueploA-P. PichéA. ChevalierS. McKercherG. BirsoyK. BarnettG. BrewerC. FarverC. NaskaT. PennellN.A. RaymondD. SchileroC. SmolenskiK. WilliamsF. MorrisonC. BorgiaJ.A. LiptayM.J. PoolM. SederC.W. JunkerK. OmbergL. DinkinM. ManikhasG. AlvaroD. BragazziM.C. CardinaleV. CarpinoG. GaudioE. CheslaD. CottinghamS. DubinaM. MoiseenkoF. DhanasekaranR. BeckerK-F. JanssenK-P. Slotta-HuspeninaJ. Abdel-RahmanM.H. AzizD. BellS. CebullaC.M. DavisA. DuellR. ElderJ.B. HiltyJ. KumarB. LangJ. LehmanN.L. MandtR. NguyenP. PilarskiR. RaiK. SchoenfieldL. SenecalK. WakelyP. HansenP. LechanR. PowersJ. TischlerA. GrizzleW.E. SextonK.C. KastlA. HendersonJ. PortenS. WaldmannJ. FassnachtM. AsaS.L. SchadendorfD. CouceM. GraefenM. HulandH. SauterG. SchlommT. SimonR. TennstedtP. OlabodeO. NelsonM. BatheO. CarrollP.R. ChanJ.M. DisaiaP. GlennP. KelleyR.K. LandenC.N. PhillipsJ. PradosM. SimkoJ. Smith-McCuneK. VandenBergS. RogginK. FehrenbachA. KendlerA. SifriS. SteeleR. JimenoA. CareyF. ForgieI. MannelliM. CarneyM. HernandezB. CamposB. Herold-MendeC. JungkC. UnterbergA. von DeimlingA. BosslerA. GalbraithJ. JacobusL. KnudsonM. KnutsonT. MaD. MilhemM. SigmundR. GodwinA.K. MadanR. RosenthalH.G. AdebamowoC. AdebamowoS.N. BoussioutasA. BeerD. GiordanoT. Mes-MassonA-M. SaadF. BocklageT. LandrumL. MannelR. MooreK. MoxleyK. PostierR. WalkerJ. ZunaR. FeldmanM. ValdiviesoF. DhirR. LuketichJ. Mora PineroE.M. Quintero-AguiloM. CarlottiC.G.Jr Dos SantosJ.S. KempR. SankarankutyA. TirapelliD. CattoJ. AgnewK. SwisherE. CreaneyJ. RobinsonB. ShelleyC.S. GodwinE.M. KendallS. ShipmanC. BradfordC. CareyT. HaddadA. MoyerJ. PetersonL. PrinceM. RozekL. WolfG. BowmanR. FongK.M. YangI. KorstR. RathmellW.K. Fantacone-CampbellJ.L. HookeJ.A. KovatichA.J. ShriverC.D. DiPersioJ. DrakeB. GovindanR. HeathS. LeyT. Van TineB. WesterveltP. RubinM.A. LeeJ.I. AredesN.D. MariamidzeA. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics.Cell20181732400416.e1110.1016/j.cell.2018.02.05229625055
     [Google Scholar]
  27. ChenB. GaoC. WangH. SunJ. HanZ. Molecular analysis of prognosis and immune infiltration of ovarian cancer based on homeobox D genes.Comput. Math. Methods Med.2022202211610.1155/2022/326838636213580
     [Google Scholar]
  28. HuangX. LiuX. WangJ. JiangY. CaoZ. WuM. ChenZ. SunR. YuP. MaJ. ZhuW. ChenY. WuG. ZhangY. Association of body mass index and abdominal obesity with incidence of atrial fibrillation in heart failure with preserved ejection fraction.Curr. Med. Chem.20233090310.2174/092986733066623060610090337282653
     [Google Scholar]
  29. KleinS.M. BozkoM. ToennießenA. MalekN.P. BozkoP. Determination of both TP53 mutation status and the amount of p53 protein has limited diagnostic importance for patients with ovarian cancer.Curr. Med. Chem.202229244293430010.2174/092986732966622011214121135023452
     [Google Scholar]
  30. WangG. LiY. PanR. YinX. JiaC. SheY. HuangL. YangG. ChiH. TianG. XRCC1: A potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.Aging (Albany NY)202416187291010.18632/aging.20542638217545
     [Google Scholar]
  31. HuangS. YinY. LiJ. ShiM. BianH. ZhaoL. Evaluation of treatments with radiotherapy alone and radiotherapy plus chemo-immunotherapy in patients with primary liver cancer based on blood biomarkers.Curr. Med. Chem.202331406586659510.2174/092986733166623082212124637608661
     [Google Scholar]
  32. ChenT. ZhuC. WangX. PanY. LncRNA ELF3-AS1 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.Can. J. Gastroenterol. Hepatol.2021202111210.1155/2021/832348734336727
     [Google Scholar]
  33. GuoJ. FengS. LiuH. ChenZ. DingC. JinY. ChenX. LingY. ZengY. LongH. QiuH. TRIM6: An upregulated biomarker with prognostic significance and immune correlations in gliomas.Biomolecules2023139129810.3390/biom1309129837759698
     [Google Scholar]
  34. PanH. LiuQ. ZhangF. WangX. WangS. ShiX. High STK40 expression as an independent prognostic biomarker and correlated with immune infiltrates in low- grade gliomas.Int. J. Gen. Med.2021146389640010.2147/IJGM.S33582134675607
     [Google Scholar]
  35. TaoS. CuiD. ChengH. LiuX. JiangZ. ChenH. GaoY. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.BMC Cancer202424119410.1186/s12885‑024‑11943‑138347489
     [Google Scholar]
  36. XieH. WuZ. LiZ. HuangY. ZouJ. ZhouH. Significance of ZEB2 in the immune microenvironment of colon cancer.Front. Genet.20221399533310.3389/fgene.2022.99533336072677
     [Google Scholar]
  37. ZhangL. QianY. An epithelial–mesenchymal transition-related prognostic model for colorectal cancer based on weighted gene co-expression network analysis.J. Int. Med. Res.202250120300060522114068310.1177/0300060522114068336510452
     [Google Scholar]
  38. HänzelmannS. CasteloR. GuinneyJ. GSVA: Gene set variation analysis for microarray and RNA-Seq data.BMC Bioinformatics2013141710.1186/1471‑2105‑14‑723323831
     [Google Scholar]
  39. BindeaG. MlecnikB. TosoliniM. KirilovskyA. WaldnerM. ObenaufA.C. AngellH. FredriksenT. LafontaineL. BergerA. BrunevalP. FridmanW.H. BeckerC. PagèsF. SpeicherM.R. TrajanoskiZ. GalonJ. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.Immunity201339478279510.1016/j.immuni.2013.10.00324138885
     [Google Scholar]
  40. ChenB. LuX. ZhouQ. ChenQ. ZhuS. LiG. LiuH. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.PLoS One2023188e029003110.1371/journal.pone.029003137582104
     [Google Scholar]
  41. YoshiharaK. ShahmoradgoliM. MartínezE. VegesnaR. KimH. Torres-GarciaW. TreviñoV. ShenH. LairdP.W. LevineD.A. CarterS.L. GetzG. Stemke-HaleK. MillsG.B. VerhaakR.G.W. Inferring tumour purity and stromal and immune cell admixture from expression data.Nat. Commun.201341261210.1038/ncomms361224113773
     [Google Scholar]
  42. LuY. WuY. TangZ. HouY. CuiM. HuangS. LongB. YuZ. IqbalM.Z. KongX. Synthesis of multifunctional Mn3O4-Ag2S janus nanoparticles for enhanced T1-magnetic resonance imaging and photo-induced tumor therapy.Sensors (Basel)20232321893010.3390/s2321893037960633
     [Google Scholar]
  43. MaimaitiA. XingliangL. ShiL. In vitro and in vivo anti-lung cancer activity of emodin: A RNA-seq transcriptome analysis.Curr. Med. Chem.20222931410.2174/0929867329666220921120314
     [Google Scholar]
  44. WangN. GanG. YangJ. WangL. Barbaloin promotes osteogenic differentiation of human bone marrow mesenchymal stem cells: Involvement of Wnt/β-catenin signaling pathway.Curr. Med. Chem.202229396100611110.2174/092986732966622062915065635770399
     [Google Scholar]
  45. LiZ. FanY. MaY. MengN. LiD. WangD. Identification of crucial genes and signaling pathways in alectinib-resistant lung adenocarcinoma using bioinformatic analysis.Mol. Biotechnol.202366123655367310.1007/s12033‑023‑00973‑y38142454
     [Google Scholar]
  46. HeW. DongS. ShenJ. WuJ. ZhaoP. LiD. WangD. TangN. ZouC. Whole-genome sequencing identified novel mutations in a Chinese family with lynch syndrome.Front. Oncol.202313103635610.3389/fonc.2023.103635636874103
     [Google Scholar]
  47. LinZ. FengF. LiangJ. ZengH. LiJ. lncRNA RP11-10A14.5: A potential prognosis biomarker for LUAD through regulation on proliferation and metastasis.Discover Oncol.20221313210.1007/s12672‑022‑00493‑235575835
     [Google Scholar]
  48. HeC. HuangD. YangF. HuangD. CaoY. PengJ. LuoX. High expression of lncRNA HEIH is helpful in the diagnosis of non-small cell lung cancer and predicts poor prognosis.Cancer Manag. Res.20221450351410.2147/CMAR.S32096535173484
     [Google Scholar]
  49. JiangX. ChenX. GuoJ. ZhouF. PuJ. MuttiL. NiuX. Identification and validation of lncRNA-AC087588.2 in lung adenocarcinoma: A novel prognostic and diagnostic indicator.Front. Mol. Biosci.2022992358410.3389/fmolb.2022.92358435769906
     [Google Scholar]
  50. LinZ. HuangW. YiY. LiD. XieZ. LiZ. YeM. LncRNA ADAMTS9-AS2 is a prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma.Int. J. Gen. Med.2021148541855510.2147/IJGM.S34068334849000
     [Google Scholar]
  51. LiX.Y. HeX.Y. ZhaoH. QiL. LuJ.J. Identification of a novel therapeutic target for lung cancer: Mitochondrial ribosome protein L9.Pathol. Res. Pract.202324815462510.1016/j.prp.2023.15462537343379
     [Google Scholar]
  52. HardenberghD. MolinaE. NaikR. GeethaD. ChaturvediS. TimlinH. Factors mediating cancer risk in systemic lupus erythematosus.Lupus202231111285129510.1177/0961203322112216336059254
     [Google Scholar]
  53. QiuJ. WangZ. YuY. ZhengY. LiM. LinC. Prognostic and immunological implications of glutathione metabolism genes in lung adenocarcinoma: A focus on the core gene SMS and its impact on M2 macrophage polarization.Int. Immunopharmacol.202413211194010.1016/j.intimp.2024.11194038593503
     [Google Scholar]
  54. ScagliottiG. Proteasome inhibitors in lung cancer.Crit. Rev. Oncol. Hematol.200658317718910.1016/j.critrevonc.2005.12.00116427303
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673359149250212073143
Loading
DDX59-AS1: A Novel Prognostic Biomarker and Immunotherapy Predictor in Lung Adenocarcinoma
Curr. Med. Chem. 33, 1651 (2026); https://doi.org/10.2174/0109298673359149250212073143
/content/journals/cmc/10.2174/0109298673359149250212073143
/content/journals/cmc/10.2174/0109298673359149250212073143
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): biomarker; cytosolic DNA sensing pathway; DDX59-AS1; immune infiltration; lung adenocarcinoma; prognosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test